BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 38247605)

  • 41. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014-2017.
    Iqbal F; Defer MK; Latif A; Hadi H
    Epidemiol Infect; 2020 Sep; 148():e253. PubMed ID: 32993828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1.
    Wattal C; Kler N; Oberoi JK; Fursule A; Kumar A; Thakur A
    Indian J Pediatr; 2020 Feb; 87(2):117-121. PubMed ID: 31828600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
    van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
    BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
    Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.
    Hansen GT
    Infect Dis Ther; 2021 Mar; 10(1):75-92. PubMed ID: 33492641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Appropriate use of antibiotics: an unmet need.
    López Romo A; Quirós R
    Ther Adv Urol; 2019; 11():1756287219832174. PubMed ID: 31105775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics, management and clinical outcomes of patients with sepsis: a multicenter cohort study in Korea.
    Jeon K; Na SJ; Oh DK; Park S; Choi EY; Kim SC; Seong GM; Heo J; Chang Y; Kwack WG; Kang BJ; Choi WI; Kim KC; Park SY; Kwak SH; Shin YM; Lee HB; Park SH; Cho JH; Kim B; Lim CM;
    Acute Crit Care; 2019 Aug; 34(3):179-191. PubMed ID: 31723927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study.
    Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration
    Lancet Glob Health; 2016 Oct; 4(10):e752-60. PubMed ID: 27633433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations.
    Rojas-Garcia P; van der Pol S; van Asselt ADI; Postma MJ; Rodríguez-Ibeas R; Juárez-Castelló CA; González M; Antoñanzas F
    Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mice Fed an Obesogenic Western Diet, Administered Antibiotics, and Subjected to a Sterile Surgical Procedure Develop Lethal Septicemia with Multidrug-Resistant Pathobionts.
    Hyoju SK; Zaborin A; Keskey R; Sharma A; Arnold W; van den Berg F; Kim SM; Gottel N; Bethel C; Charnot-Katsikas A; Jianxin P; Adriaansens C; Papazian E; Gilbert JA; Zaborina O; Alverdy JC
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: "Attack on Titan".
    Mancuso G; De Gaetano S; Midiri A; Zummo S; Biondo C
    Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb S; Beale RJ; Vincent JL; Moreno R;
    Intensive Care Med; 2013 Feb; 39(2):165-228. PubMed ID: 23361625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.